Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Multiscale Methods in Drug Design Bridge Chemical and Biological Complexity in the Search for Cures
The peptide works by promoting angiogenesis, which is the formation of new blood vessels
Its potential to accelerate tissue regeneration has made it a promising candidate for addressing joint pain, mobility issues, and injury recovery
Legal Disclaimer This product is intended for laboratory research purposes only and is not approved for human or veterinary use
Retatrutide (development code LY3437943) is a 39-amino acid synthetic peptide developed by Eli Lilly as the first triple-receptor agonist targeting GLP-1R, GIPR, and GCGR in a single molecule
US$ 20.61
US$ 29.07
US$ 27.09
US$ 25.00
US$ 27.30
US$ 23.11
US$ 23.92
US$ 27.24
US$ 27.55
